ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Radiopharm Theranostics Ltd

Radiopharm Theranostics Ltd (RADX)

4,24
-0,01
( -0,24% )
Aktualisiert: 18:10:27

Radiopharm Theranostics Ltd (RADX) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
4,24
( -0,24% )
Gebot
4,15
Fragen
4,25
Volumen
11.951
4,11 Tagesbereich 4,40
3,62 52-Wochen-Bereich 16,25
Marktkapitalisierung
Handelsende
4,25
Handelsbeginn
4,18
Letzte Trade
12
@
4.17
Letzter Handelszeitpunkt
18:59:06
Finanzvolumen
US$ 51.204
VWAP
4,2845
Durchschnittliches Volumen (3 Mio.)
US$ 1.795.442
Ausgegebene Aktien
3.544.216.160
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-1
Gewinn pro Aktie (EPS)
-0,02
Erlöse (LTM)
16,28M
Nettogewinn (LTM)
-46,58M

Über Radiopharm Theranostics Ltd

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain me... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Carlton, Australia
Gegründet
2026
Radiopharm Theranostics Ltd is listed in the Healthcare sector of the NASDAQ with ticker RADX. The last closing price for Radiopharm Theranostics was US$4,25. Over the last year, Radiopharm Theranostics shares have traded in a share price range of US$ 3,62 to US$ 16,25.

Radiopharm Theranostics currently has 3.544.216.160 shares in issue. The market capitalisation of Radiopharm Theranostics is US$15,03 billion. Radiopharm Theranostics has a price to earnings ratio (PE ratio) of -1.00.

RADX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.081.923076923084.164.46993.95318964.15141242DR
4-0.255-5.672969966634.4954.743.95235084.28462983DR
12-0.18-4.072398190054.424.823.95317754.41955183DR
26-1.02-19.3916349815.265.54793.9998804.37223689DR
52-0.22-4.932735426014.4616.253.622301938.57054982DR
156-1.36-24.28571428575.650.823.49621878937.94336861DR
260-1.36-24.28571428575.650.823.49621878937.94336861DR

RADX - Frequently Asked Questions (FAQ)

What is the current Radiopharm Theranostics Ltd share price?
The current share price of Radiopharm Theranostics Ltd is US$ 4,24
How many Radiopharm Theranostics Ltd shares are in issue?
Radiopharm Theranostics Ltd has 3.544.216.160 shares in issue
What is the market cap of Radiopharm Theranostics Ltd?
The market capitalisation of Radiopharm Theranostics Ltd is USD 15,03B
What is the 1 year trading range for Radiopharm Theranostics Ltd share price?
Radiopharm Theranostics Ltd has traded in the range of US$ 3,62 to US$ 16,25 during the past year
What is the PE ratio of Radiopharm Theranostics Ltd?
The price to earnings ratio of Radiopharm Theranostics Ltd is -1
What is the cash to sales ratio of Radiopharm Theranostics Ltd?
The cash to sales ratio of Radiopharm Theranostics Ltd is 4,14
What is the registered address of Radiopharm Theranostics Ltd?
The registered address for Radiopharm Theranostics Ltd is 62 Lygon Street, Carlton, Victoria, 3053
What is the Radiopharm Theranostics Ltd website address?
The website address for Radiopharm Theranostics Ltd is www.radiopharmtheranostics.com
Which industry sector does Radiopharm Theranostics Ltd operate in?
Radiopharm Theranostics Ltd operates in the Biotechnology & Life Sciences sector

RADX Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen